Quantcast

Industry news that matters to you.  Learn more

Psychemedics Launches New Hair Alcohol Test

Psychemedics Corporation (NASDAQ: PMD), hair testing pioneer and global leader for over twenty-five years, announced the launch of its hair alcohol test – a test that measures average alcohol consumption over a period of approximately three months, indicates the level of alcohol use during that time period, and can provide a behavioral indication of excessive use.

Alcohol is the most abused substance in the world, and excessive use poses serious health and safety issues to society. In other regions of the world, this test has been used effectively in the courts, corporate alcohol screening programs, and in monitoring medical issues and probation compliance. Psychemedics’ new hair alcohol test provides answers about alcohol abuse and can be an indicator of those dependent on alcohol.

The test measures the amount of ethyl glucuronide (EtG) in the hair – a trace metabolite of ethanol and a direct alcohol biomarker – and follows the guidelines determined by the World Health Organization in association with the Society of Hair Testing for measuring consumption.

This non-invasive testing procedure uses a small sample of hair that is easily collected and shipped. All work is done by Psychemedics’ College of American Pathologists (CAP) and ISO/IEC 17025:2005 certified laboratory.

Advancing The Science Of Hair Testing

Psychemedics established its technological and market leadership position in 1987 with the development of the first hair test to detect drugs of abuse. Continued advancement in the science of hair testing is critical to Psychemedics, and this new alcohol test provides clients with another method to identify substance abuse.

Raymond C. Kubacki, Chairman and CEO stated, “We are excited to announce the availability of this new hair alcohol test. Our company has, for over twenty-five years, offered the most effective hair testing technology based upon scientifically validated drug testing methods. After many years of investing time and research into developing a hair alcohol test, we are proud to now provide the market with a reliable test to measure alcohol consumption over a period of time.”

Source: Psychemedics Corporation

Study Advances Use of Stem Cells in Personalized Medicine

Johns Hopkins researchers report concrete steps in the use of human stem cells to test how diseased cells respond to drugs. Their success highlights a pathway toward faster, cheaper drug development for some genetic illnesses, as well as the ability to pre-test a therapy’s safety and effectiveness on cultured clones of a patient’s own cells.

United States Drug Testing Laboratories Unveils New Alcohol Biomarker in Umbilical Cord

United States Drug Testing Laboratories (USDTL), a reference laboratory specializing in alcohol and drugs of abuse testing, today released a new assay testing umbilical cord for newborn alcohol exposure in utero. The CordStat EtOH assay screens for the direct alcohol biomarker phosphatidylethanol (PEth), an abnormal phospholipid formed in cell tissues following alcohol ingestion.

ApoCell Launches Revolutionary Circulating Cancer Cell Detection System

ApoCell, Inc. announced earlier this week that it has completed the first prototype to commercialize a revolutionary technology that improves the detection of more types of cancer cells circulating in the blood, including rare cell types that have previously gone undetected. Invented by scientists at The University of Texas MD Anderson Cancer Center’s Laboratory of Diagnostic Microsystems and exclusively licensed to ApoCell, a leader in biomarker analysis, the technology also enables the capture of circulating tumor cells (CTCs) in a live and viable state, enabling post-detection testing and culturing.